Clinical Study
Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer
Table 6
Coexpression of Her2/neu and p53 according to HmR status.
| variable | Her2/neu+ and inactive p53 | Her2/neu− and intact p53 | Her2/neu+ and intact p53 | Her2/neu− and inactive p53 | Total | P value |
| HmR+ | 0 | 51 | 3 | 20 | 74 | <0.0001 | HmR− | 9 | 3 | 8 | 1 | 21 |
| Total | 9 | 54 | 11 | 21 | 95 | |
|
|